KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Short term Debt (2016 - 2023)

Historic Short term Debt for West Pharmaceutical Services (WST) over the last 15 years, with Q3 2023 value amounting to $2.2 million.

  • West Pharmaceutical Services' Short term Debt changed 0.0% to $2.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $44.2 million for FY2021, which is 182173.91% up from last year.
  • As of Q3 2023, West Pharmaceutical Services' Short term Debt stood at $2.2 million, which was down 0.0% from $2.2 million recorded in Q2 2023.
  • West Pharmaceutical Services' Short term Debt's 5-year high stood at $44.2 million during Q3 2021, with a 5-year trough of $2.2 million in Q1 2022.
  • In the last 5 years, West Pharmaceutical Services' Short term Debt had a median value of $2.3 million in 2019 and averaged $7.8 million.
  • As far as peak fluctuations go, West Pharmaceutical Services' Short term Debt soared by 220000.0% in 2019, and later tumbled by 9502.26% in 2022.
  • Quarter analysis of 5 years shows West Pharmaceutical Services' Short term Debt stood at $2.3 million in 2019, then changed by 0.0% to $2.3 million in 2020, then soared by 1821.74% to $44.2 million in 2021, then crashed by 95.02% to $2.2 million in 2022, then changed by 0.0% to $2.2 million in 2023.
  • Its last three reported values are $2.2 million in Q3 2023, $2.2 million for Q2 2023, and $2.2 million during Q1 2023.